Advertisement

Topics

Search Results for "Abbott Dartford Murex Biotech Ltd"

17:40 EDT 29th April 2016 | BioPortfolio

Matching Channels

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Abbott to Acquire Alere for 5.8B

Abbott has announced a definitive agreement to acquire Alere, significantly advancing Abbott’s global diagnostics presence and leadership. Abbott will pay $56 per common share at a total expecte...

Beijing Strong Biotech Grants Technology License to Abbott

Beijing Strong Biotechnologies (BSBE) recently signed a technology license granting Abbott Labs rights to its clinical chemistry testing products, which BSBE currently manufactures in China. Initially...

Abbott to Gain Leadership in POC Diagnostics upon Acquisition of Alere

Abbott and Alere have reached a definitive agreement under which Abbott will pay an equity value of about USD 5.8...

Abbott Laboratories will Diagnostik-Spezialisten Alere schlucken

ABBOTT PARK (dpa-AFX) - Der US-Pharmakonzern Abbott Laboratories will seine Diagnostiksparte mit einem Milliardenzukauf verstärken. Für den kleineren Wettbewerber Alere bietet der Konzern 56 US-Do.....

Abbott deal for St. Jude spurs company split talk

When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Mil...

Abbott Issues 2016 Earnings Outlook

NORTH CHICAGO (dpa-AFX) - Abbott (ABT) announced the company expects full-year 2016 earnings per share, excluding specified items, in the range of $2.10 to $2.20. Abbott's 2016 forecast assumes a ...

Abbott buys diagnostics company Alere

Abbott Laboratories (NYSE:ABT) is acquiring diagnostics play Alere Inc. (NYSE:ALR) for $56 per share in cash, or about $5.8 billion. Abbott said it will assume or refinance Alere's net debt of $2.6 bi...

Abbott Hosts Conference Call for First-Quarter Earnings

ABBOTT PARK, Ill., March 28, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2016 financial results on Wednesday, April 20, 2016, before the market opens.  The anno...

Matching PubMed Articles

Evaluation of Copan FLOQSwab for the molecular detection of Chlamydia trachomatis by Abbott RealTime CT PCR.

We evaluated Copan FLOQSwabs next to Abbott swabs for the detection of Chlamydia trachomatis (CT) by Abbott RealTime PCR.

Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens.

The automated high-throughput Abbott RealTime MTB real-time PCR assay has been recently launched for Mycobacterium tuberculosis complex (MTBC) clinical diagnosis. This study would like to evaluate its...

Neuro-oncology biotech industry progress report.

The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015...

Old boy biotech.

Second-quarter biotech job picture.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement